Seven NIH Scientists Honored by ASM
|ASM fellows are (clockwise, from above) Dr. Jeffrey Cohen, Dr. Kim Green, Dr. Peter Kwong, Dr. Thomas Nutman, Dr. Theodore Pierson, Dr. Alan Rein and Dr. Zhi-Ming Zheng.
Seven NIH scientists are among 88 new fellows
recently elected to the American Academy of Microbiology
in recognition of their records of scientific
achievement and original contributions that have
advanced microbiology. The fellows will be honored
at the American Society for Microbiology’s annual
meeting in Boston on May 20.
Dr. Jeffrey I. Cohen, chief, Laboratory of Infectious
Dr. Kim Y. Green, chief, caliciviruses section, Laboratory
of Infectious Diseases, NIAID
Dr. Peter Kwong, chief, structural biology section
and structural bioinformatics core section, Vaccine
Research Center, NIAID
Dr. Thomas Nutman, head, helminth immunology
section and head, clinical parasitology section, Laboratory
of Parasitic Diseases, NIAID
Dr. Theodore Pierson, chief, viral pathogenesis section,
Laboratory of Viral Diseases, NIAID
Dr. Alan Rein, head, retroviral
HIV Drug Resistance Program,
Dr. Zhi-Ming Zheng,
senior investigator and
head, tumor virus RNA
biology section, Gene
Regulation and Chromosome
NIAAA’s Warren Receives Lifetime Achievement Award
The Research Society on Alcoholism has selected NIAAA deputy director Dr. Kenneth R. Warren to receive the RSA Lifetime Achievement Award. The award recognizes a person with a long, balanced career whose contributions to alcohol research, training, service and advocacy have had a lasting impact on the field.
Warren is a distinguished scientific administrator and a foremost expert on the effects of alcohol use during pregnancy. More than 30 years ago, he initiated NIAAA’s research program on fetal alcohol syndrome (FAS). For his work on the development of the first Surgeon General’s Advisory on Alcohol Use in Pregnancy, Warren received a Superior Service Award from the Public Health Service in 1982. Currently, Warren chairs the interagency coordinating committee on fetal alcohol spectrum disorders.
Warren joined NIAAA in 1976 and has provided leadership in various roles, including as associate director for basic research. In February 2008, he was appointed deputy director. He served as NIAAA acting director from November 2008 to January 2014.
The RSA has honored Warren previously with the Seixas Award for Service and the Henry Rosett Award from the FAS study group. The National Organization on Fetal Alcohol Syndrome (NOFAS) inducted him into the Tom and Linda Daschle FASD Hall of Fame and more recently honored him with the NOFAS Excellence Award.
NEI’s Brooks Honored
Dr. Brian Brooks of NEI has been elected to the American Society for Clinical Investigation (ASCI). The society publishes the Journal of Clinical Investigation and elects the journal’s editor-in-chief from its ranks.
ASCI accepts membership nominations internationally and elects a maximum of 80 new members each year based on a record of achievement in biomedical research. Because new members must be 50 years of age or younger, the society particularly recognizes scientists who are productive early in their careers.
Brooks leads NEI’s unit on pediatric, developmental and genetic ophthalmology. His research focuses on the genetic and developmental causes of uveal coloboma, a potentially blinding condition in which tissue in or around the eye is missing from birth. He also performs clinical and basic research on potential treatments for vision loss associated with albinism.
He was inducted into ASCI at a ceremony on Apr. 25 as part of the 2014 joint meeting between ASCI and the Association of American Physicians in Chicago.
Heart Institute Alumnus Sjoerdsma Mourned
Dr. Albert Sjoerdsma, 89, whose research at NIH in the 1950s and 1960s helped define the field of clinical pharmacology, died Feb. 27 in Southern Shores, N.C. He suffered cardiac arrest after an extended illness.
Sjoerdsma arrived at the National Heart Institute in 1953. For nearly 20 years, he explored a range of biochemical and medical targets in the Experimental Therapeutics Branch, first as senior investigator (1953-1958) and later as chief (1958-1971). He diagnosed and defined the carcinoid syndrome, an unusual cancer characterized by serotonin-filled tumors; established the mechanism of action of the first antidepressants, monoamine oxidase inhibitors; and measured serotonin, dopamine and other amines in bananas and other foods. He also discovered the antihypertensive Aldomet, a drug still used today; developed treatments for pheochromocytoma and scleroderma; probed the biochemical nature of rapid-eye-movement sleep and more.
“We had a factory going, practically speaking,” he said of his NIH work. “We were a wild bunch.” Sjoerdsma also admitted some of the first patients to the Clinical Center when it opened in 1953.
Sjoerdsma trained in cardiology at Michael Reese Hospital in Chicago. He received two bachelor’s degrees, a doctorate in pharmacology and a medical degree from the University of Chicago. He also served in the Army Reserves from 1942 to 1944.
He retired in 1971 from the Public Health Service after 20 years of service and left NIH for a pharmaceutical company. He went on to develop drugs for epilepsy, African sleeping sickness and an antihistamine. He eventually became president of Merrell Dow Research Institute.
In 1996, he retired to the Outer Banks of North Carolina. Sjoerdsma published more than 300 scientific papers, received numerous awards and honors and held a dozen patents.
He is survived by his wife of 63 years, Dr. Fern MacAllister Sjoerdsma of Southern Shores; daughters Leslie Swink of Jacksonville, Fla., Ann Sjoerdsma of Southern Shores and Britt Sjoerdsma of Sarasota, Fla.; son, Albert Sjoerdsma Jr. of Ann Arbor, Mich.; brother Peter Sjoerdsma of Punta Gorda, Fla.; two grandchildren, three nephews, a niece and numerous cousins.
A memorial service will be held in Kitty Hawk, N.C., in September.
Volkow Marks 10th Year as NIDA Director
NIDA director Dr. Nora Volkow receives a pin from deputy director Dr. Wilson Compton marking her 10-year anniversary as director on Apr. 17. Volkow has pioneered the use of brain imaging to investigate the effects of drugs in the human brain and has been instrumental in demonstrating that drug addiction is a brain disease. She has published more than 600 scientific articles and edited 3 books. She has received multiple awards including membership in the Institute of Medicine. She has also been named one of Time magazine’s “Top 100 People Who Shape Our World,” included as “One of the 20 People to Watch” by Newsweek magazine and named “Innovator of the Year” by U.S. News & World Report.